DNAII:

Hiroyuki Miyachi1, Masaki Koshimizu1, Masashi Suzuki1

  • 1Lead Exploration Unit, Drug Discovery Initiative, University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan.

概括

研究人员开发了一个紧的二氧化平台 (C-D-DAP),以扩大DNA编码库 (DEL) 中的化学多样性. 这使得能够发现针对酶和G蛋白结合受体 (GPCRs) 的新型候选药物.

相关概念视频

Molecules and Compounds02:38

Molecules and Compounds

Atoms and Molecules
68.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.4K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
136.1K